FDA Adverse Event Other Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 2582790 · Received May 18, 2012

Report

Report Number
1220423-2012-00015
Event Type
Other
Date Received
May 18, 2012
Report Date
May 11, 2012
Manufacturer
GENZYME BIOSURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TW
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

MFR'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF SYNVISC IS NOT AFFECTED BY THIS REPORT.

Description of Event or Problem · 1

INFECTION AFTER CESAREAN [POST PROCEDURAL INFECTION]. CASE DESCRIPTION: SPONTANEOUS REPORT WAS RECEIVED ON (B)(6) 2012 FROM A PHYSICIAN REGARDING A FEMALE PT, INITIALS UNK. THE PT'S MEDICAL HISTORY IS SIGNIFICANT FOR CESAREAN SECTION. ON AN UNSPECIFIED DATE, THE PT INITIATED SEPRAFILM MEMBRANE, ONE SHEET. ON AN UNSPECIFIED DATE, THE PT EXPERIENCED INFECTION AFTER CESAREAN. THE PT REQUIRED INTERVENTION IN THE FORM OF RE-OPERATION (DETAILS NOT PROVIDED). THE PT RECOVERED FROM THE EVENT OF INFECTION AFTER CESAREAN (DATE NOT PROVIDED). CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE INTENSITY FOR THE EVENT OF INFECTION AFTER CESAREAN WAS ASSESSED AS MILD. THE REPORTER ASSESSED THE RELATIONSHIP BETWEEN SEPRAFILM AND THE EVENT OF INFECTION AFTER CESAREAN AS UNASSESSABLE. THE PRODUCT LOT NUMBER WAS REPORTED AS 10NP574.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME BIOSURGERY (SEPRAFILM/PACK) UNK 10NP574

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention